Key result
Concomitant tricuspid repair during mitral surgery fails to reduce moderate TR but is linked to AF.
Why the study?
Whether tricuspid valve repair should be performed during degenerative mitral valve repair in patients with less than moderate regurgitation remains controversial.
Does concomitant tricuspid valve repair prevent the development of moderate tricuspid regurgitation in patients with less than moderate tricuspid regurgitation undergoing degenerative mitral valve repair?
Cohort (n=541)
No
Does concomitant tricuspid valve repair prevent the development of moderate tricuspid regurgitation in patients with less than moderate tricuspid regurgitation undergoing degenerative mitral valve repair?
Answers are grounded in this paper and cite their sources.
Concomitant tricuspid valve repair during degenerative mitral valve surgery for less than moderate TR does not prevent future TR progression and increases the risk of new-onset atrial fibrillation.
BACKGROUND: Whether tricuspid valve (TV) repair should be performed during degenerative mitral valve repair in patients with less than moderate regurgitation remains controversial. OBJECTIVES: This study aimed to explore the clinical outcomes of degenerative mitral valve repair for less than moderate tricuspid regurgitation (TR). METHODS: Between 2010 and 2019, 541 patients with less than moderate TR underwent mitral valve repair for degenerative mitral disease at the Beijing Anzhen Hospital. Among these patients, 255 underwent concomitant TV repair. The median follow-up was 8 years (Q1-Q3: 6-11 years). The primary endpoint was the development of moderate TR. The secondary endpoint was death, recurrent mitral regurgitation (MR), reoperation for MR or TR, new-onset atrial fibrillation, and permanent pacemaker implantation. Propensity score matching was performed to reduce selection bias. RESULTS: After baseline adjustment, propensity score matching analysis identified 207 pairs. There were no significant differences in the primary endpoints between the patients who underwent simultaneous TV repair and those who did not. Mortality, recurrent MR, permanent pacemaker implantation, and reoperation for MR or TR did not differ significantly between groups. Concomitant TV repair only contributed to new-onset atrial fibrillation, with 24 (11.6%) in the TV-repair group and 7 (3.4%) in the no-repair group (P = 0.001). CONCLUSIONS: Considering its minimal effects on the development of TR and potential contributions to postoperative new-onset atrial fibrillation during follow-up among these patients, more aggressive TV repair is not encouraged among patients with less than moderate TR during MV surgery.
No takes yet. Share an insight, caveat, or question.
Du et al. (2025) conducted a cohort in Degenerative mitral disease with less than moderate tricuspid regurgitation (n=541). Concomitant tricuspid valve repair vs. No tricuspid valve repair was evaluated on Development of moderate tricuspid regurgitation (HR 0.323, 95% CI 0.093-1.127, p=0.125). Concomitant tricuspid valve repair during degenerative mitral valve surgery for less than moderate tricuspid regurgitation did not reduce the development of moderate tricuspid regurgitation but increased the risk of new-onset atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: